PharmGen Science Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Lee Seung-Yeol
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
Recent updates
PharmGen Science's (KRX:004720) Shareholders Have More To Worry About Than Only Soft Earnings
Mar 27Is Wooridul Pharmaceutical (KRX:004720) A Risky Investment?
Mar 21Investors Who Bought Wooridul Pharmaceutical (KRX:004720) Shares Five Years Ago Are Now Up 55%
Jan 19Does The Market Have A Low Tolerance For Wooridul Pharmaceutical Limited's (KRX:004720) Mixed Fundamentals?
Dec 21Are Wooridul Pharmaceutical's (KRX:004720) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 25CEO
Lee Seung-Yeol (43 yo)
no data
Tenure
Seung-Yeol Lee serves as the Chief Executive Officer of PharmGen Science Inc. (formerly known as Wooridul Pharmaceutical Limited). Seung-Yeol Lee serves as the President of Winnova Co., Ltd. Seung-Yeol Lee...